Osteoporosis

The patient is a -- year old --- who presents for follow up of ---.

__ has h/o of osteoporosis.
-Current treatment includes Janumet 50/1000mgBID and repaglinide 1mg with meals.
-Her most recent A1c 7.7%  - repeat pending.
She monitors her blood glucose 2 times daily.
Her fasting glucose levels varies from >110mg/dL. ( unhealthy food choices have contributed to her elevated blood glucose.)
She has no polydipsia, polyuria, increased appetite, fatigue or change in vision.
Disease complications do not include peripheral neuropathy, diabetic retinopathy or diabetic nephropathy.

Hyperglycemia due to type 2 diabetes mellitus (E11.65)
Story: A1c <6.5%
70 to 110mg pre meals
<140 2hr post meals
Impression: Lifestyle changes re-enforced.
Current Plans
Continued Janumet 50-1000 MG Oral Tablet, 1 (one) Tablet two times daily, #180, 90 days starting 03/25/2021, Ref. Q 90 Days x1 Year.
Continued Repaglinide 0.5 MG Oral Tablet, 1 (one) Tablet three times daily, #270, 90 days starting 03/25/2021, Ref. Q 90 Days x1 Year.
HEMOGLOBIN GLYCLATED (HGB A1C) (83036)
METABOLIC PANEL, BASIC (80048)
Discussed Daily Self Foot Exams with patient.
Discussed eye care with the patient.
Patient instructed to follow a low carbohydrate diet.
Discussed regular exercise with patient.
Follow up in 3 months or as needed
The patient is a -- year old --- who presents for follow up of ---.

__ has h/o of osteoporosis.
-Current treatment includes Janumet 50/1000mgBID and repaglinide 1mg with meals.
-Her most recent A1c 7.7%  - repeat pending.
She monitors her blood glucose 2 times daily.
Her fasting glucose levels varies from >110mg/dL. ( unhealthy food choices have contributed to her elevated blood glucose.)
She has no polydipsia, polyuria, increased appetite, fatigue or change in vision.
Disease complications do not include peripheral neuropathy, diabetic retinopathy or diabetic nephropathy.

Hyperglycemia due to type 2 diabetes mellitus (E11.65)
Story: A1c <6.5%
70 to 110mg pre meals
<140 2hr post meals
Impression: Lifestyle changes re-enforced.
Current Plans
Continued Janumet 50-1000 MG Oral Tablet, 1 (one) Tablet two times daily, #180, 90 days starting 03/25/2021, Ref. Q 90 Days x1 Year.
Continued Repaglinide 0.5 MG Oral Tablet, 1 (one) Tablet three times daily, #270, 90 days starting 03/25/2021, Ref. Q 90 Days x1 Year.
HEMOGLOBIN GLYCLATED (HGB A1C) (83036)
METABOLIC PANEL, BASIC (80048)
Discussed Daily Self Foot Exams with patient.
Discussed eye care with the patient.
Patient instructed to follow a low carbohydrate diet.
Discussed regular exercise with patient.
Follow up in 3 months or as needed

Result - Copy and paste this output:

Sandbox Metrics: Structured Data Index 0, 189 boilerplate words
Questions/General site feedback

Send Feedback for this SOAPnote

This site uses Akismet to reduce spam. Learn how your comment data is processed.

More SOAPnotes by this Author: